Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer

Fig. 6

A. Cytotoxicity assays of JQ1 and GSK2801 against three TNBC cell lines. A. Viability curves explaining the cytotoxic effect of JQ1 and GSK2801 when treated alone on MDA-MB-231, HCC-1806 and SUM-159 TNBC cell lines. B. Viability curves explaining the cytotoxic effect of combined treatments of JQ1 and GSK2801 on MDA-MB-231, HCC-1806 and SUM-159 cell lines demonstrating the synergistic effect. Values are given as mean of three independent experiments ± SD. B. Quantification of the cell density. Bar plots showing the cell densities measured after the treatment. There is a progressive decrease in the cell density with increasing drug concertation. The cell densities are lower in the combined treatment when compared to single agent treatment

Back to article page